Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Edelweiss | HDFC |
| NAV | ₹33.4822 | ₹22.8170 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 8.7 years | 3.1 years |
| Expense ratio | 2.7% | 2.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 44.70 | 93.90 |
Returns
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +5.80% | +12.87% |
| 3 months | +2.08% | +6.85% |
| 6 months | +19.60% | +17.20% |
| YTD | +23.82% | +32.43% |
| 1 year | +22.21% | +30.73% |
| 3 years (CAGR) | +15.66% | +29.16% |
| 5 years (CAGR) | +9.59% | — |
| 10 years (CAGR) | — | — |
| Since launch | +14.82% | +30.28% |
Risk
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 20.9% | 15.8% |
| Downside volatility | 13.1% | 8.6% |
| Sharpe | 0.44 | 1.44 |
| Sortino | 0.70 | 2.64 |
| Calmar | 0.63 | 1.94 |
| Return / risk | 0.75 | 1.85 |
| Deepest fall | −32.34% | −15.07% |
| Days to recover | 155 | 133 |
| Below its high | −1.65% | +0.00% |
Against benchmark
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | +4.43% | +6.36% |
| Beta | 0.97 | 0.97 |
| R² | 56.3% | 85.0% |
| Up capture | 111.0% | 106.7% |
| Down capture | 96.2% | 74.4% |
| Tracking error | 13.8% | 6.1% |
| Information ratio | 0.31 | 0.97 |
| Treynor | 0.09 | 0.22 |
Consistency
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +97.69% | +64.96% |
| Middle 1-year | +16.18% | +21.84% |
| Worst 1-year | −24.34% | +0.52% |
| 1-year periods with a loss | 26.2% | 0.0% |
| Middle 3-year | +17.58% | +28.68% |
| Positive months | 66.7% | 69.4% |
| Best day | +3.68% | +3.19% |
| Worst day | −5.79% | −3.62% |
| Worst 5% day | −1.94% | −1.50% |
| Positive days | 57.4% | 58.1% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Edelweiss Recently Listed IPO Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +16.40% | — |
| 5-year value | ₹9,11,471 | — |
| 3-year XIRR | +16.90% | +26.26% |
| 1-year XIRR | +33.64% | +39.84% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.